首页|期刊导航|中国中医药图书情报杂志|基于网络药理学及分子对接技术探讨膝痹散治疗膝骨关节炎作用机制

基于网络药理学及分子对接技术探讨膝痹散治疗膝骨关节炎作用机制OA

Exploration on the Mechanism of Xibi Powder in the Treatment of Knee Osteoarthritis Based on Network Pharmacology and Molecular Docking Technology

中文摘要英文摘要

目的 采用网络药理学和分子对接技术探讨膝痹散治疗膝骨关节炎(KOA)的作用机制.方法 检索TCMSP、HERB和SwissTargetPrediction数据库获取膝痹散活性成分及对应靶点,检索GeneCards、DisGeNET和OMIM数据库获取KOA靶点信息.使用Venny 2.1.0在线平台绘制膝痹散治疗KOA交集靶点,利用Cytoscape软件构建中药-活性成分-疾病-靶点网络,并基于度值筛选关键成分.通过蛋白相互作用(PPI)网络筛选核心靶点.使用DAVID数据库对交集靶点进行GO功能富集分析及KEGG富集分析.运用AutoDock Vina软件对核心靶点及关键成分进行分子对接验证.结果 共得到膝痹散活性成分189个、对应靶点761个,药物与疾病交集靶点307个,关键活性成分为槲皮素、卡兰金、木犀草素、尼里醋酸酯、松香胺,核心靶点为IL6、TNF、AKT1、GAPDH、ALB.GO功能富集分析获得1 085个生物过程条目、116个细胞组分条目及227个分子功能条目.KEGG富集分析显示出184条相关通路,包括AGE-RAGE、TNF、HIF-1、IL-17和PI3K-Akt等信号通路.分子对接结果显示,膝痹散治疗KOA的关键成分与核心靶点均具有较好的结合性.结论 膝痹散可能通过槲皮素、卡兰金、木犀草素等活性成分作用于IL6、TNF、AKT1等关键靶点,调控AGE-RAGE、TNF、HIF-1、IL-17等信号通路发挥治疗KOA作用.

Objective To explore the mechanism of Xibi Powder in treating knee osteoarthritis(KOA)using network pharmacology and molecular docking technology.Methods The active components and corresponding targets of Xibi Powder were retrieved from the TCMSP,HERB and SwissTargetPrediction databases.KOA-related targets were obtained from the GeneCards,DisGeNET and OMIM databases.The intersecting targets of Xibi Powder against KOA were identified using the Venny 2.1.0 online platform.A drug-active component-disease-target network was constructed using Cytoscape software,and key components were screened based on degree values.Core targets were further identified through a protein-protein interaction(PPI)network.Gene Ontology(GO)functional enrichment and Kyoto Encyclopedia of Genes and Genomes(KEGG)enrichment analyses were performed on key targets using the DAVID database.Finally,molecular docking validation of core targets and key components was conducted using AutoDock Vina software.Results A total of 189 active components and 761 corresponding targets were identified for Xibi Powder.Among them,307 intersecting targets between the drug and disease were obtained,with the key active components being quercetin,karanjin,luteolin,neryl acetate,songoramine.The core targets included IL6,TNF,AKT1,GAPDH and ALB.GO functional enrichment analysis yielded 1 085 biological process terms,116 cellular component terms,and 227 molecular function terms.KEGG enrichment analysis revealed 184 related pathways,including the AGE-RAGE,TNF,HIF-1,IL-17 and PI3K-Akt signaling pathways.Molecular docking results demonstrated that the key components of Xibi Powder had good binding affinity with the core targets in the treatment of KOA.Conclusion Xibi Powder may exert therapeutic effects on KOA by regulating signaling pathways such as AGE-RAGE,TNF,HIF-1 and IL-17 through active ingredients,including quercetin,karanjin and luteolin,which act on key targets such as IL-6,TNF and AKT1.

张云华;李平

重庆市南川区中医医院,重庆 408400重庆中医药学院附属第一医院,重庆 400021

医药卫生

膝痹散膝骨关节炎网络药理学分子对接活性成分槲皮素

Xibi Powderknee osteoarthritisnetwork pharmacologymolecular dockingactive componentsquercetin

《中国中医药图书情报杂志》 2026 (5)

26-31,38,7

重庆市科卫联合中医药科研项目(2023MSXM183)重庆市南川区科技局2023年度第四批科技计划(Cx202337)

10.3969/j.issn.2095-5707.202502131

评论